Poland· PL-100478970

Ebvallo

A tabelecleucel product containing tabelecleucelum, registered in Poland by Pierre Fabre Medicament. The same ATC class is registered in 11 of our 19 countries.

ATC L01XL09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEbvalloATCL01XL09REGISTER NO.PL-100478970PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Tabelecleucel is registered in 11 of 19 countries.

Countries holding a registration under ATC L01XL09 (tabelecleucel), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Tabelecleucel · ATC L01XL09

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Tabelecleucelum
Manufacturer
Pierre Fabre Medicament
Country
Poland (PL)
ATC code
L01XL09
ATC class
Tabelecleucel
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    03573994007258
  • gtin
    03573994006497
  • gtin
    03573994006480
  • gtin
    03573994006527
  • gtin
    03573994006510
  • gtin
    03573994006503
  • gtin
    03573994006534

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/27bbe5da-0668-4a56-b96f-cd9293d1e4fd
GET /v1/drugs/27bbe5da-0668-4a56-b96f-cd9293d1e4fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dyspersja do wstrzykiwań",
  "source": "urpl",
  "strength": "2,8 × 10^7 – 7,3 × 10^7 komórek/ml",
  "packaging": "03573994007258 ¦ Lz ¦ EU/1/22/1700/001 ¦ 148592\n1 fiol. 2 ml (1 do 6 fiol.)\n03573994006497 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158533\n2 fiol. 2 ml\n03573994006480 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158534\n1 fiol. 2 ml\n03573994006527 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158535\n5 fiol. 2 ml\n03573994006510 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158536\n4 fiol. 2 ml\n03573994006503 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158537\n3 fiol. 2 ml\n03573994006534 ¦ Lz ¦ EU/1/22/1700/001 ¦ 158538\n6 fiol. 2 ml",
  "substance": "Tabelecleucelum 2,8 × 10^7 – 7,3 × 10^7 komórek/ml",
  "common_name": "Tabelecleucelum",
  "pl_product_id": "100478970",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about tabelecleucel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.